bioRxiv Science⌕ Search

Biology subjects

van Riel, N. A.

Publications and source records attributed to van Riel, N. A..

2 recordsLinked to original sources

Glycolysis revisited: from steady state growth to glucose pulses

Kinetic metabolic models of central metabolism have been proposed to understand how Saccharomyces cerevisiae navigates through nutrient perturbations. Yet, these models lacked important variables that constrain metabolism under relevant physiological conditions and thus have limited operational use such as in optimization of industrial fermentations. In this work, we developed a physiologically informed kinetic model of yeast glycolysis connected to central carbon metabolism by including the effect of anabolic reactions precursors, mitochondria and the trehalose cycle. A parameter estimation pipeline was developed, consisting of a divide and conquer approach, supplemented with regularization and global optimization. We show how this first mechanistic description of a growing yeast cell captures experimental dynamics at different growth rates and under a strong glucose perturbation, is robust to parametric uncertainty and explains the contribution of the different pathways in the network. Our work suggests that by combining multiple types of data and computational methods, complex but physiologically representative and robust models can be achieved.

systems biology↗

The Digital Mouse: why computational modelling of mouse models of disease can improve translation

Computational models can be used to study the mechanistic phenomena of disease. Current mechanistic computer simulation models mainly focus on (patho)physiology in humans. However, often data and experimental findings from preclinical studies are used as input to develop such models. Biological processes underlying age-related chronic diseases are studied in animal models. The translation of these observations to clinical applications is not trivial. As part of a group of international scientists working in the COST Action network MouseAGE, we argue that in order to boost the translation of pre-clinical research we need to develop accurate in silico counterparts of the in vivo animal models. The Digital Mouse is proposed as framework to support the development of evidence-based medicine, for example to develop geroprotectors, which are drugs that target fundamental mechanisms of ageing. HighlightsO_LIComputational modelling of human (patho)physiology is advancing rapidly, often using and extrapolating experimental findings from preclinical disease models. C_LIO_LIThe lack of in silico models to support in vivo modelling in mice is a missing link in current approaches to study complex, chronic diseases. C_LIO_LIThe development of mechanistic computational models to simulate disease in mice can boost the discovery of novel therapeutic interventions. C_LIO_LIThe Digital Mouse is proposed as a framework to implement this ambition. The development of a Digital Mouse Frailty Index (DM:FI) to study aging and age-related diseases is provided as an example. C_LI

bioengineering↗